78
Views
9
CrossRef citations to date
0
Altmetric
Liver and Biliary Tract

Determination of hepatic galactose elimination capacity using 2-[18F]fluoro-2-deoxy-d-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model

Pages 98-103 | Received 18 May 2010, Accepted 18 Jul 2010, Published online: 09 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Martti Färkkilä. (2011) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:1, pages 3-5.
Read now

Articles from other publishers (8)

Yi-Fang Yang, Chien-Hsiu Li, Huei-Yu Cai, Bo-Syuan Lin, Cheorl-Ho Kim & Yu-Chan Chang. (2022) Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis. International Journal of Molecular Sciences 23:24, pages 15831.
Crossref
Tongxi Li, Junjie Bai, Yichao Du, Peng Tan, Tianxiang Zheng, Yifan Chen, Yonglang Cheng, Tianying Cai, Meizhou Huang, Wenguang Fu & Jian Wen. (2022) Thiamine pretreatment improves endotoxemia-related liver injury and cholestatic complications by regulating galactose metabolism and inhibiting macrophage activation. International Immunopharmacology 108, pages 108892.
Crossref
Michael Sørensen, Mette Marie Fode, Jørgen Baltzer Petersen, Marianne Ingerslev Holt & Morten Høyer. (2021) Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT. Radiation Oncology 16:1.
Crossref
Mette Marie Fode, Jørgen Baltzer Petersen, Michael Sørensen, Marianne Ingerslev Holt, Susanne Keiding & Morten Høyer. (2017) 2-[18F]fluoro-2-deoxy-d-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours. Physics and Imaging in Radiation Oncology 1, pages 28-33.
Crossref
Ana I. Coelho, Gerard T. Berry & M. Estela Rubio-Gozalbo. (2015) Galactose metabolism and health. Current Opinion in Clinical Nutrition and Metabolic Care 18:4, pages 422-427.
Crossref
Michael Sørensen, Kasper S. Mikkelsen, Kim Frisch, Gerda E. Villadsen & Susanne Keiding. (2013) Regional metabolic liver function measured in patients with cirrhosis by 2-[18F]fluoro-2-deoxy-d-galactose PET/CT. Journal of Hepatology 58:6, pages 1119-1124.
Crossref
Michael Sørensen, Kasper Sandager Mikkelsen, Kim Frisch, Ludvik Bass, Bo Martin Bibby & Susanne Keiding. (2011) Hepatic Galactose Metabolism Quantified in Humans Using 2- 18 F-Fluoro-2-Deoxy-d-Galactose PET/CT . Journal of Nuclear Medicine 52:10, pages 1566-1572.
Crossref
Michael Sørensen, Kim Frisch, Dirk Bender & Susanne Keiding. (2011) The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 38:9, pages 1723-1731.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.